KemPharm Announces 1-For-16 Reverse Stock Split

Shares of the Company’s common stock are expected to begin trading on a split-adjusted basis on Monday, December 28, 2020. The Reverse Stock Split is intended to enable the Company to potentially regain its listing on the Nasdaq Capital Market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.